Superficial venous thrombosis (SVT) has received increased attention as more clinicians are recognizing the potential morbidity of untreated disease. Traditional therapies aimed at symptom control and disruption of the saphenofemoral junction (SFJ) are being called into question.

2015年4月23日 · Treatment aims are symptom relief and prevention of venous thromboembolism (VTE) in relation to the thrombotic burden. SVT of the long saphenous vein within 3 cm of the saphenofemoral junction (SFJ) is considered to be equivalent to a DVT, and thus deserving of therapeutic anticoagulation.

Treatment aims are symptom relief and prevention of venous thromboembolism (VTE) in relation to the thrombotic burden. SVT of the long saphenous vein within 3 cm of the saphenofemoral junction (SFJ) is considered to be equivalent to a DVT, and …

2016年12月28日 · SVT >5cm or <3 cm from the SFJ should be treated with anti-coagulation. The rate of concurrent DVT and PE in patients with SVT is 25% and 5%, respectively.

2011年8月31日 · Superficial venous thrombosis (SVT) has received increased attention as more clinicians are recognizing the potential morbidity of untreated disease. Traditional therapies aimed at symptom control and disruption of the saphenofemoral junction (SFJ) are …

In the placebo group of the CALISTO study (Comparison of Arixtra in lower LImb Superficial vein ThrombOsis with placebo), 1 thromboembolic complications occurred more often when the SVT involved the great saphenous vein (GSV), was extended to within 10 cm of the saphenofemoral junction (SFJ), involved veins above the knee, and in patients with ...

2013年9月5日 · Ninety-two percent of patients with extension had initial SVT involving the greater saphenous vein. Thus, extension into the SFJ, an accepted risk factor for deep venous propagation of SVT, would seem a likely risk factor for further complications.

2017年8月18日 · SVT >5cm or <3 cm from the SFJ should be treated with anti-coagulation. The rate of concurrent DVT and PE in patients with SVT is 25% and 5%, respectively.

• Important: If thrombus within 3cm of saphenofemoral junction (SFJ), treat as DVT. • If < 5cm, symptomatic management only eg NSAIDs. Consider repeat scan if no improvement at 1 week or earlier if progressive symptoms. • If >5cm and ONE of: above knee involvement, severe symptoms, involvement of LSV, history of DVT or

2014年12月17日 · The involvement of the perforating veins or an SVT <3 cm from the sapheno-femoral junction (SFJ) was found to increase the risk significantly. The odds ratios for concomitant DVT were 8·1 and 3·3 respectively. Indeed, the proximity of SVT to the SFJ has long been accepted as a risk factor for developing complications.